https://www.reuters.com/business/aerospace-defense/exclusive-boeing-does-not-expect-faa-approval-max-10-before-summer-2023-letter-2022-10-04/
Israeli Ministry Of Health Clears Way For Human Trials Of Allocetra
The Israeli Ministry of Health (MOH) approved a Phase I/II trial of Enlivex Therapeutics Ltd.’s (NASDAQ:ENLV) proprietary immunotherapy drug-candidate AllocetraTM.
AllocetraTM is a cell therapy that uses healthy